Evp, Managing Director, Consulting
Current
Jan 2024 - Present
AeroLeads people directory · profile
Greg Gregory, Phd Email & Phone Number
Executive Vice President & Managing Director, Consulting | Market Access, Pricing, and Commercialization Strategist | Biopharmaceuticals, Orphan Drugs, & Vaccines
at
Precision AQ
1 work email found
@insightstrat.com
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Executive Vice President & Managing Director, Consulting | Market Access, Pricing, and Commercialization Strategist | Biopharmaceuticals, Orphan Drugs, & Vaccines
Location
Greater Philadelphia, United States, United States
Who is Greg Gregory, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Greg Gregory, Phd is listed as Executive Vice President & Managing Director, Consulting | Market Access, Pricing, and Commercialization Strategist | Biopharmaceuticals, Orphan Drugs, & Vaccines at Precision AQ, based in Greater Philadelphia, United States, United States. AeroLeads shows a work email signal at insightstrat.com and a matched LinkedIn profile for Greg Gregory, Phd.
Greg Gregory, Phd previously worked as EVP, Managing Director, Consulting at Precision Aq and Executive Vice President, Managing Director at Precisionadvisors. Greg Gregory, Phd holds Phd, Immunology & Molecular Pathogenesis from Emory University.
Company email context
Email format at Precision AQ
This section adds company-level context without repeating Greg Gregory, Phd's masked contact details.
*@insightstrat.com
68% confidence
AeroLeads found 1 current-domain work email signal for Greg Gregory, Phd. Compare company email patterns before reaching out.
Profile bio
About Greg Gregory, Phd
As an executive leader in market access strategy, I bring 25 years of experience spanning academia and consulting. The first decade of my career was spent in academic research, focusing on immunology, hematology, and oncology, where I developed a strong foundation in bioscience and analytical thinking. For the past 15 years, I have applied that expertise to consulting, leading one of the premier boutique teams in the world known for delivering transformative insights and solutions. My work bridges defendable strategic pricing, contracting, value demonstration, and distribution, with deep experience launching life-saving/changing therapies across rare diseases, vaccines, and specialty therapeutics.I lead with a focus on curiosity and innovation, recognizing the need for forward-thinking strategies in an industry shaped by CMS negotiations, global pricing pressures, and evolving payer landscapes. My work includes shaping market access frameworks for the launch of groundbreaking therapies and integrating advanced analytics to address the intersection of payer, providers, and patients.As part of the executive leadership team, I’ve driven organizational transformation by fostering cross-functional collaboration and empowering my team to connect the dots across disciplines. Whether aligning clinical trial designs with payer expectations or designing go-to-market strategies that redefine launch excellence, I position clients for sustainable success in an increasingly dynamic environment.Looking ahead, I remain committed to shaping the market access landscape by helping clients navigate emerging challenges and capitalize on opportunities. By combining strategic foresight with practical execution, I strive to drive impactful change that ensures patients have timely access to innovative therapies while addressing the evolving needs of the biopharma ecosystem.When I'm not working, I spend as much time as I can with my family. I enjoy travel, new experiences in new countries, and beaches worldwide.SPECIALTIES:• Executive Leadership in Market Access & Commercialization Strategy• Strategic Pricing and Contracting• Distribution Models and Patient Support Services• Rare Diseases, Vaccines, and Specialty Therapeutics• Strategic Vision for Navigating Complex Market EnvironmentCONTACT INFO:Email: greg.gregory@precisionaq.com
Listed skills include Biotechnology, Immunology, Pharmaceutical Industry, Market Access, and 23 others.
Current workplace
Greg Gregory, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles · 26 years
Greg Gregory, Phd work experience
A career timeline built from the work history available for this profile.
Executive Vice President, Managing Director
Dec 2021 - Dec 2023
Senior Vice President, Managing Director, And Head Of Commercial Launch Excellence
I provide senior leadership within PRECISONadvisors and am responsible for operations and growth, as well as convergence between opportunities with other PRECISION Value & Health and Precision for Medicine business units. I also deliver thought leadership in rare diseases, vaccines, and digital therapeutics.PRECISIONadvisors provides real-world experience.
Apr 2020 - Dec 2021
Senior Vice President, Global Pricing, Market Access, & Analytics
After Precision Medicine Group acquired Insight Strategy Advisors, I continued to focus on sales, delivery, growth, and professional development of the team. As part of my senior executive responsibilities, I expanded my expertise to include operations.
Jul 2018 - Apr 2020
Vice President
My expanded role included increased responsibility for sales, delivery, growth, and professional development of the team. Precision Medicine Group acquired Insight Strategy Advisors in 2018.
Sep 2017 - Jul 2018
Senior Engagement Manager
I focused primarily on project delivery and business development. In addition, I established the Orphan Drug/Rare Disease practice at the company and expanded our vaccine go-to-market strategy expertise. I created a new role for operational excellence and helped that team member evolve the position to become Director of Operations.
May 2013 - Sep 2017
Senior Engagement Manager, Commercial Excellence
My journey on the consulting side of the industry began here. I rose through a series of positions with increasing responsibility, starting at the company as an Analyst and building up the Philadelphia office. I focused on project delivery, client management, and early business development.
Jan 2010 - Apr 2013
Nrsa Postdoctoral Fellowship
My mentor was Dr. Gerd A. Blobel, as I investigated epigenetic mechanisms of gene expression and how they contribute to the development of hematological disorders and the immune system. I also co-authored several publications in leading scientific journals, including Blood, EMBO J, and Molecular and Cellular Biology.I was invited to present a paper at.
May 2006 - Jan 2010
Life Sciences Consultant
Penn Biotech Group/ Pbg Healthcare Consulting
I evaluated the market potential of a novel drug for treating three distinct metabolic diseases with recommendations leading to the initiation of an out-licensing process for the candidate drug. I collaborated in developing a strategy for determining the value of a new biological technology for the ethanol industry. Primary data collection included.
Jan 2008 - Jan 2009
Graduate Student
I continued my doctoral dissertation work with Dr. Brown at Northwestern University. I characterized epigenetic mechanisms regulating gene expression in mast cells and tested novel therapeutic agents to inhibit mast cells to treat multiple sclerosis.
2003 - 2006
~3 yrs
Graduate Student, Immunology And Molecular Pathogenesis
I utilized in vivo models to better understand the contribution of mast cells to the autoimmune disease multiple sclerosis, under the tutelage of my graduate advisor, Dr. Melissa A. Brown. I also investigated epigenetic mechanisms contributing to disease susceptibility and co-authored several scientific publications (e.g., Journal of Clinical.
2000 - 2005
~5 yrs
Laboratory Teaching Assistant
Jan 2002 - Apr 2002
Technical Assistant Iv
I worked at the University of Rochester Medical Center’s General Clinical Research Center. I supported specimen analysis and banking for diabetes and muscular dystrophy-related clinical trials.
May 1998 - Sep 1999
2 education records
Greg Gregory, Phd education
Phd, Immunology & Molecular Pathogenesis
Emory University
Bs, Microbiology
University Of Rochester
FAQ
Frequently asked questions about Greg Gregory, Phd
Quick answers generated from the profile data available on this page.
What company does Greg Gregory, Phd work for?
Greg Gregory, Phd works for Precision AQ.
What is Greg Gregory, Phd's role at Precision AQ?
Greg Gregory, Phd is listed as Executive Vice President & Managing Director, Consulting | Market Access, Pricing, and Commercialization Strategist | Biopharmaceuticals, Orphan Drugs, & Vaccines at Precision AQ.
What is Greg Gregory, Phd's email address?
AeroLeads has found 1 work email signal at @insightstrat.com for Greg Gregory, Phd at Precision AQ.
Where is Greg Gregory, Phd based?
Greg Gregory, Phd is based in Greater Philadelphia, United States, United States while working with Precision AQ.
What companies has Greg Gregory, Phd worked for?
Greg Gregory, Phd has worked for Precision Aq, Precisionadvisors, Precision Xtract, Insight Strategy Advisors, and Inventiv Health Consulting (Formerly Campbell Alliance).
How can I contact Greg Gregory, Phd?
You can use AeroLeads to view verified contact signals for Greg Gregory, Phd at Precision AQ, including work email, phone, and LinkedIn data when available.
What schools did Greg Gregory, Phd attend?
Greg Gregory, Phd holds Phd, Immunology & Molecular Pathogenesis from Emory University.
What skills is Greg Gregory, Phd known for?
Greg Gregory, Phd is listed with skills including Biotechnology, Immunology, Pharmaceutical Industry, Market Access, Managed Care, Cell Biology, Project Management, and Strategic Consulting.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial